Clinical Trial Update: Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

View source ↗

Summary

Clinical trial update investigating recurrence monitoring of hepatocellular carcinoma using a 5-Hydroxymethylcytosine biomarker test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN